tm logo
ORCHESTRATING THE IMMUNE SYSTEM
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 05 Mar 2024

Last Applicant/ Owned by

410 W Harrison Street, Suite 150

Seattle

WA

98119

Serial Number

97518230 filed on 25th Jul 2022

Registration Number

N/A

Correspondent Address

Connie Ellerbach

FENWICK & WEST LLP

801 CALIFORNIA STREET

MOUNTAIN VIEW,CA 94041

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ORCHESTRATING THE IMMUNE SYSTEM

Pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders; biological products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases aRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders; biological products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; pharmaceutical products and preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; biological products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic and medicinal products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; diagnostic biomarker reagents for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, and cancer; diagnostic agents, preparations, and substances for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders

Mark Details


Serial Number

No 97518230

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 37379-00070

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
06th Mar 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05th Mar 2024SOU TEAS EXTENSION RECEIVED
05th Mar 2024SOU EXTENSION 1 FILED
05th Mar 2024SOU EXTENSION 1 GRANTED
31st Oct 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05th Sep 2023PUBLISHED FOR OPPOSITION
05th Sep 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16th Aug 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03rd Aug 2023APPROVED FOR PUB - PRINCIPAL REGISTER
10th Jul 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED